Bionano Genomics Inc.

Bionano is proud to support the search for cures! Read the blog post to learn more about how Saphyr users are advancing cancer research. #worldcancerday https://bit.ly/3trMwQv

Publication on novel Saphyr based method to analyze DNA methylation in cancer genomes enables new field of cancer research and drug target discovery. https://bit.ly/3aq8MBN

Presentation now available on-demand: Bionano's Chief Medical Officer, Dr. Alka Chaubey, at Festival of Genomics 2021. Dr. Chaubey presented the vision for optical genome mapping with Saphyr as a first-line clinical tool for cancer and genetic disease. https://bit.ly/3ov2GVH

Dr. Gordana Raca from Children's Hospital Los Angeles reported on the performance of optical genome mapping (OGM) for the clinical analysis of pediatric acute leukemias, demonstrating how OGM detected clinically important SVs that can alter patient care and treatment decisions. https://bit.ly/3j1ibng

Chief Medical Officer, Dr. Alka Chaubey, presented at The Festival of Genomics & Biodata evidence supporting her vision of Optical Genome Mapping (OGM) with Saphyr as a first line test in genetic disease and cancer. As a first line test, OGM would be the first test applied to diagnose the patient and to determine their prognosis and management strategy. https://bit.ly/3pASmgl